Apellis Pharmaceuticals, Inc. short interest in 2025
In 2025, Apellis Pharmaceuticals, Inc.'s disclosed short interest ran from 14.50% of shares outstanding on 15 Jan 2025 to 12.74% on 31 Dec 2025, a change of -1.76 percentage points. The year's high was 22.89% on 30 Apr 2025 and its low 12.02% on 31 Oct 2025, averaging 16.44% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 14.00 days on 30 Jun 2025. Full history: Apellis Pharmaceuticals, Inc..
Cite this page
By year: 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2025 in figures
- Start of year
- 14.50% (15 Jan 2025)
- End of year
- 12.74% (31 Dec 2025)
- Change
- -1.76 pp
- High
- 22.89% (30 Apr 2025)
- Low
- 12.02% (31 Oct 2025)
- Average
- 16.44%
- Highest days to cover
- 14.00 (30 Jun 2025)
- SEC filings marked
- 5
Every report in 2025
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 15 Jan 2025 | 14.50% | 7.15 | results (8-K) |
| 31 Jan 2025 | 13.71% | 11.57 | |
| 14 Feb 2025 | 13.94% | 12.04 | |
| 28 Feb 2025 | 16.73% | 11.98 | 10-K filed |
| 14 Mar 2025 | 15.53% | 13.18 | |
| 31 Mar 2025 | 18.10% | 10.40 | |
| 15 Apr 2025 | 21.57% | 8.71 | |
| 30 Apr 2025 | 22.89% | 12.71 | |
| 15 May 2025 | 21.68% | 8.11 | 10-Q filed |
| 30 May 2025 | 19.92% | 9.96 | |
| 13 Jun 2025 | 20.00% | 11.08 | |
| 30 Jun 2025 | 20.81% | 14.00 | |
| 15 Jul 2025 | 13.12% | 8.47 | |
| 31 Jul 2025 | 17.49% | 7.26 | 10-Q filed |
| 15 Aug 2025 | 16.05% | 6.96 | |
| 29 Aug 2025 | 16.26% | 11.61 | |
| 15 Sep 2025 | 17.23% | 9.67 | |
| 30 Sep 2025 | 16.67% | 9.31 | |
| 15 Oct 2025 | 14.30% | 8.09 | |
| 31 Oct 2025 | 12.02% | 4.43 | 10-Q filed |
| 14 Nov 2025 | 12.92% | 5.59 | |
| 28 Nov 2025 | 12.72% | 7.55 | |
| 15 Dec 2025 | 13.63% | 7.71 | |
| 31 Dec 2025 | 12.74% | 7.29 |
See also: Apellis Pharmaceuticals, Inc.'s full history · most shorted US stocks of 2025 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.